Your browser is no longer supported. Please, upgrade your browser.
Settings
HSTO Histogen Inc. daily Stock Chart
HSTO [NASD]
Histogen Inc.
Index- P/E- EPS (ttm)-3.63 Insider Own0.10% Shs Outstand12.21M Perf Week-12.12%
Market Cap18.63M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float8.36M Perf Month-26.02%
Income-18.00M PEG- EPS next Q- Inst Own4.80% Short Float0.36% Perf Quarter-65.05%
Sales5.00M P/S3.73 EPS this Y42.10% Inst Trans14.26% Short Ratio0.27 Perf Half Y-53.23%
Book/sh1.38 P/B1.05 EPS next Y- ROA-85.10% Target Price- Perf Year-55.38%
Cash/sh- P/C- EPS next 5Y38.00% ROE-104.20% 52W Range1.30 - 7.50 Perf YTD-63.75%
Dividend- P/FCF- EPS past 5Y25.00% ROI-59.40% 52W High-80.67% Beta1.57
Dividend %- Quick Ratio2.90 Sales past 5Y- Gross Margin93.00% 52W Low11.54% ATR0.16
Employees5 Current Ratio3.00 Sales Q/Q-99.10% Oper. Margin- RSI (14)24.62 Volatility9.32% 9.75%
OptionableYes Debt/Eq0.05 EPS Q/Q-666.10% Profit Margin- Rel Volume0.23 Prev Close1.47
ShortableYes LT Debt/Eq0.05 Earnings- Payout- Avg Volume110.43K Price1.45
Recom3.00 SMA20-16.31% SMA50-37.61% SMA200-59.20% Volume25,187 Change-1.36%
Sep-16-20 08:00AM  
Sep-10-20 08:00AM  
Sep-01-20 04:15PM  
Aug-13-20 04:05PM  
Jul-30-20 04:15PM  
Jul-29-20 04:15PM  
Jul-20-20 04:10PM  
Jul-14-20 05:00AM  
Jun-03-20 08:00AM  
Histogen Inc., a regenerative medicine company, develops therapies based upon the products of cells grown under simulated embryonic conditions. It offers human multipotent cell conditioned media (CCM); human extracellular matrix (hECM); and hair stimulating complex (HSC). The company's technology focuses on stimulating a patient's own stem cells by delivering a complex of multipotent human proteins that support stem cell growth and differentiation. Histogen Inc. is headquartered San Diego, California.